Services

Our services

At Idea Therapeutics, we provide a comprehensive approach to advanced therapy development, supporting each project from early stages through to final implementation.

Our services combine scientific expertise, technical capabilities, and agile execution to turn innovation into real-world solutions, adapting to the specific needs of every project.

Gene Therapy Medicines

Contain therapeutic genes to treat diseases such as genetic disorders, cancer and chronic conditions.

Source: EMA

Somatic-Cell Therapy Medicines

Use cells or tissues modified to diagnose, prevent or treat diseases.

Source: EMA

Tissue-Engineered Medicines

Focus on repairing, or replace damaged tissues.

Source: EMA

 

Integrated solutions across the full value chain — from concept to market

R&D

Intellectual Property

GMP Manufacturing

Preclinical & Clinical studies

Regulatory Affairs

Commercialization

Are you a researcher, a startup, an established company or an investor?

Let’s enlighten your business together.

Researcher

If you have an idea, we can bring your research to project to market.

Which ideas do we choose?

  • Projects in biotech and advanced therapies
  • Focus on scalability and market potential

Startup

We can co-develop and invest in new biotech products, bringing your project to the next level.

What can we offer you? We guide you along the whole value chain:
  • Expertise in IP and RA services
  • Support in Preclinical and Clinical studies
  • GMP manufacturing of ATMPs in our facilities

Estabilished company

If you are interested in licensing opportunities or joint development in any territory, let’s talk.

What are you interested in?
  • Advanced Therapy Medicinal Products (ATMPs)
  • Dermatology
  • Immunology
  • Rare diseases
  • Cancer

Investor

If you are looking for promising biotech opportunities with tangible market potential, let’s talk.

Are you interested in…
  • High-growth biotech opportunities
  • Partnering in breakthrough ATMPs
  • Long-term collaboration
  • Innovation-driven leadership